Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hepatic Histopathological Benefit, Microbial Cost: Oral Vancomycin Mitigates Non-Alcoholic Fatty Liver Disease While Disrupting the Cecal Microbiota

International Journal of Molecular Sciences(2025)10.3390/ijms26178616Source: DataRank Database

Hepatic Histopathological Benefit, Microbial Cost: Oral Vancomycin Mitigates Non-Alcoholic Fatty Liver Disease While Disrupting the Cecal Microbiota is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.77)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Selma Aydemir ORCID,Burcu Açıkgöz ORCID,Aslı Çelik,Yunus Bahadır Güler ORCID,Müge Kıray ORCID

Live enrichment

PubMed:40943536 PMC:PMC12429848 OpenAlex:https://openalex.org/W4414024477

Scientific Research Projects Coordination Unit of Dokuz Eylül University

Grant: TKB-2022-2664

FWCI

0.77

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/26/17/8616/pdf?version=1756988002

publisherhttps://www.mdpi.com/1422-0067/26/17/8616/pdf?version=1756988002

publisherhttps://www.mdpi.com/1422-0067/26/17/8616/pdf

journalhttps://doi.org/10.3390/ijms26178616

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40943536

Fields of Study

Liver Disease Diagnosis and TreatmentGut microbiota and healthLiver Diseases and ImmunityAnimalsVancomycinNon-alcoholic Fatty Liver DiseaseGastrointestinal MicrobiomeCecumMaleMiceMice, Inbred C57BLLiverDisease Models, AnimalMethionineAdministration, OralCytokinesAnti-Bacterial AgentsRNA, Ribosomal, 16S

MeSH Terms

Gastrointestinal MicrobiomeAdministration, OralAnimalsAnti-Bacterial AgentsCecumDisease Models, AnimalLiverMaleMethionineMice, Inbred C57BLRNA, Ribosomal, 16SVancomycinCytokinesMiceNon-alcoholic Fatty Liver Disease

Keywords

Fatty liverAlcoholic liver diseaseVancomycinMedicineGut floraGastroenterologyDiseaseInternal medicineBiologyBacteriaStaphylococcus aureusImmunologyCirrhosisMicrobiotaNon-alcoholic fatty liver diseaseCytokeratin 18Oral VancomycinLiver InflammationMice Ubiquitin